Clinical use of electronic portal imaging: Report of AAPM Radiation Therapy Committee Task Group 58 by Herman, Michael G. et al.
Clinical use of electronic portal imaging: Report of AAPM Radiation
Therapy Committee Task Group 58
Michael G. Hermana)
Division of Radiation Oncology, Mayo Clinic, Rochester, Minnesota 55905
James M. Balter
Radiation Oncology Department, University of Michigan, Ann Arbor, Michigan 48109
David A. Jaffray
Radiation Oncology Department, William Beaumont Hospital, Royal Oak, Michigan 48073
Kiarin P. McGee
Department of Radiology, Mayo Clinic, Rochester, Minnesota 55902
Peter Munro
Physics Department, London Regional Cancer Centre, London Ontario N6A 4L6, Canada
Shlomo Shalev
Masthead Imaging, Nanaimo, British Columbia V9R 2R2, Canada
Marcel Van Herk
Radiotherapy Department, Netherlands Cancer Institute, Amsterdam, The Netherlands
John W. Wong
Radiation Oncology Department, William Beaumont Hospital, Royal Oak, Michigan 48073
~Received 19 January 2001; accepted for publication 1 March 2001!
AAPM Task Group 58 was created to provide materials to help the medical physicist and col-
leagues succeed in the clinical implementation of electronic portal imaging devices ~EPIDs! in
radiation oncology. This complex technology has matured over the past decade and is capable of
being integrated into routine practice. However, the difficulties encountered during the specifica-
tion, installation, and implementation process can be overwhelming. TG58 was charged with pro-
viding sufficient information to allow the users to overcome these difficulties and put EPIDs into
routine clinical practice. In answering the charge, this report provides; comprehensive information
about the physics and technology of currently available EPID systems; a detailed discussion of the
steps required for successful clinical implementation, based on accumulated experience; a review of
software tools available and clinical use protocols to enhance EPID utilization; and specific quality
assurance requirements for initial and continuing clinical use of the systems. Specific recommen-
dations are summarized to assist the reader with successful implementation and continuing use of
an EPID. © 2001 American Association of Physicists in Medicine. @DOI: 10.1118/1.1368128#
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I. INTRODUCTION
A critical requirement in radiation therapy is accurate day-
to-day treatment setup. Early studies based on port films in-
dicated the benefits of portal verification.1–4 Numerous sub-
sequent studies have characterized the magnitude and nature
of setup errors for a variety of clinical conditions. Random
and systematic errors of up to 6 mm ~s! have been reported
in previous studies.2,3,5–24
An effective means to reduce setup error would be to
increase the frequency of treatment verification with portal
imaging.25 Such action using port film is time consuming and
labor intensive and can reduce throughput in a busy radiation
therapy department. In addition, quantitative interpretation of
geometric discrepancies is difficult and tedious to perform
with nondigital imaging systems.26 The need for an im-
proved portal imaging system to enhance verification of con-
formal radiation therapy spurred the development of on-line
electronic portal imaging devices ~EPIDs!.
The modern era of electronic portal imaging began in the
early 1980s with demonstration by the late Norman Baily of
the use of a fluoroscopic system to acquire megavoltage
transmission images.27 The introduction of the scanning liq-
uid ionization chamber system in 1990 was quickly followed
by the introduction of camera-based fluoroscopic EPIDs
from other manufacturers. At present, EPIDs are commer-
cially available in the US from at least five vendors. Initially,
these devices were embraced with great expectation by the
radiation therapy community. At the time when Task Group
58 ~TG58! was formed in 1995, about 250 systems had been
sold in the US. In years since, informal surveys indicate that
the initial promise has not led to widespread clinical appli-
cation of EPIDs. An informal survey of 69 institutions with
EPIDs, conducted by members of TG58, indicated that 25%
do not use the devices at all. The most common mode of
operation is for the radiotherapists to perform visual inspec-
tion of the patient setup as a first line of action to reduce
large setup errors or mistakes. Only 50% of the surveyed
institutions have secondary review stations and only half of
these appear to have comprehensive analysis tools. About
40% of the institutions with EPIDs have developed a com-
prehensive quality assurance ~QA! program, but fewer thanMedical Physics, Vol. 28, No. 5, May 2001half of these perform the program regularly. Thirty-five per-
cent of respondents do not have a QA program at all. The
majority of users surveyed consider image quality from cur-
rent EPIDs inferior to that of port films and thus the EPID is
not used, contrary to statements of superior EPID resolution
repeatedly made in the literature. On the other hand, EPIDs
are used because many users believe that these devices save
time and provide quantitative feedback.
It is clear that EPID technology is underutilized in the US.
Furthermore, EPIDs are not used to produce their intended
clinical benefit. Despite the impressive clinical results of Eu-
ropean studies,28,29 it remains clear that apparent hurdles
limit EPID utilization in the US. TG58 was formed to help
AAPM members understand and implement EPID technol-
ogy. It is the goal of this report to provide information to
enhance and encourage effective use of these powerful de-
vices.
The specific charges of Task Group 58 are as follows.
~1! To provide comprehensive technical information about
the operation, limitations, and system characteristics of
the various commercially available EPIDs for the pur-
pose of implementation, use, and developing quality as-
surance programs.
~2! To summarize existing experience on the effective
implementation and use of the EPID for imaging in vari-
ous clinical treatment sites and conditions from simple
film replacement to quantitative statistical methods.
~3! To describe tools currently available for on-line and off-
line evaluations of the images.
~4! To specify the requirements and discuss issues related to
quality assurance for EPID systems, including the ar-
chive and management of the large amount of imaging
data.
Aside from Sec. I, the TG58 report consists of five major
sections and a summary. Section II presents the physics of
portal imaging. The effects of photon energies, dose, noise,
imaging geometry, and other factors on image quality are
discussed. A basic understanding of these relationships is
important in maintaining optimal operation of EPIDs. In Sec.
III, the technologies employed in commercially available
EPIDs are described. Section IV describes the pertinent steps
that the medical physicist needs to take to commission an
EPID for clinical imaging and to maintain it in optimal op-
erating condition. In Sec. V, complicated issues related to
clinical implementation and use are discussed. Several
modes of clinical operation to achieve various degrees of
improvement in setup accuracy are introduced; each with
different requirements of manpower, software tools, and
computer resources. In Sec. VI, basic cost analysis for clini-
cal adaptation of the EPIDs is discussed. The section ends
with a projection of future trends in the use of EPIDs. Sec-
tion VII offers a summary and recommendations from the
Task Group.
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Treatment verification usually involves comparison of a
portal image acquired during a treatment fraction with a ref-
erence image that is generated prior to the initiation of the
treatment course. Sometimes, the first approved portal image
is also used as the reference image. While the portal image is
formed by the megavoltage beam used to treat the patient,
the reference image can be kilovoltage ~e.g., simulation
film!, megavoltage, or a digitally reconstructed radiograph.
It is generally accepted that the quality of images acquired
using megavoltage x rays is inherently poorer than that ac-
quired with kilovoltage x rays. Besides the well-known de-
crease in subject contrast ~e.g., the differential attenuation
between bone or air and soft tissues! as the energy of an
x-ray beam increases, many other factors contribute to the
poor quality of portal images. These include the performance
of the image receptor, x-ray scatter due to patient thickness,
the size of the x-ray source, noise in the human eye–brain
system, and ~indirectly! the position of the image receptor.
The purpose of this section is to explain how these factors
influence the portal image quality and to understand the fun-
damental limitations of imaging with megavoltage x-ray
beams. This in turn should help readers understand what they
can and cannot expect from the imaging performance of
EPIDs.
A number of key quantities give an objective measure of
image quality. Figure 1 illustrates the image formation pro-
cess and its relation to some key indicators of image quality.
This section addresses contrast, noise, spatial resolution, de-
tective quantum efficiency ~DQE! of EPIDs, and x-ray scat-
ter.
A. Contrast
Contrast, C, describes how much an object stands out
from its surroundings and is defined as30
C5
signal
mean signal 5
fp22fp1
~fp21fp112fs!/2
, ~1!
where fp1, fp2, and fs are the primary and scatter photon
FIG. 1. Schematic representation of the imaging process. Fluences f are
defined in text.Medical Physics, Vol. 28, No. 5, May 2001fluences reaching the image receptor ~Fig. 1!. Motz and
Danos have shown that this expression can be rewritten as30
C5
2~12e2D!
11e2D1
2SF
12SF
, ~2!
where D is the difference in attenuation between the object
and the background ~i.e., D5Lxumbone2mwateru), mbone and
mwater are the x-ray attenuation coefficients for bone and wa-
ter, respectively, Lx is the thickness of the anatomic struc-
ture, and SF is the scatter fraction $SF5fs(fs1fp)%. Equa-
tion ~1! shows that the contrast is increased by increasing the
difference in attenuation along the x-ray path and is de-
creased by the addition of a scatter fluence.
Subject contrast of 1-cm-thick bone or air objects embed-
ded within 20 cm of water as a function of x-ray energy can
be calculated using Eq. ~2!. For simplicity, the contrast has
been calculated assuming that no x-ray scatter occurs ~i.e.,
SF50!. For comparison purposes, 50 keV approximates the
mean energy of the x-ray energy spectra used to generate a
simulator image ~100 kVp, diagnostic energy! and 2 MeV
that of the 6 MV beam to generate a portal image. Examin-
ing the subject contrast at these two x-ray energies shows the
subject contrast decreases from 0.5 to 0.037 ~a factor of 13!
for the bone and from 0.2 to 0.05 for the air pocket ~only a
factor of 4!. This explains the enhanced visibility of the air
passages relative to bony anatomy seen in the therapy image
as compared to the simulator image.
Contrast is the result of differences in x-ray attenuation
within the patient. At low energies, the photoelectric process
dominates. Since the photoelectric cross section is propor-
tional to the atomic number raised to the third power (Z3),
the higher atomic number of bone results in a larger attenu-
ation coefficient compared to that of water. However, the
photoelectric cross section is also inversely proportional to
the energy cubed (1/E3). Compton scattering becomes the
dominant interaction process above 20 keV for soft tissues
and above 50 keV for bone ~assuming that the atomic num-
ber of bone is ;13!. The Compton scattering cross section is
dependent on the electron density of a material, which, ex-
cept for hydrogen, varies only slightly with atomic number.
The electron density of water @re(water)53.34
31023 electrons/cm3# is comparable to that of bone
@re(bone)55.8131023 electrons/cm3# . Therefore, the differ-
ence in attenuation, and hence the contrast, reduces signifi-
cantly at megavoltage energies.
B. Signal-to-noise ratio
1. Quantum noise
The most important concept to understand is that image
quality ~or ‘‘detectability’’ of bony anatomy! is ultimately
determined not by the subject contrast of the object being
imaged but by the signal-to-noise ratio ~SNR! of the image.
A number of sources of noise contribute to the SNR. A lim-
iting source of noise is due to x-ray quantum statistics. This
is best explained again with Fig. 1, which shows the process
of x-ray image formation. The difference in attenuation be-
715 Herman et al.: TG58 715tween an object and its surroundings ~i.e., subject contrast!
results in different number of x-ray quanta reaching and in-
teracting in an image receptor. The subject contrast is deter-
mined by the energy of the x-ray beam, the radiological
properties of the object being imaged, and the amount of
x-ray scatter reaching the image receptor. However, since
image formation is a statistical process involving the detec-
tion of discrete x-ray quanta, there will be a statistical uncer-
tainty ~known as x-ray quantum mottle! in the number of
x-ray quanta that interact in the image receptor. The detect-
ability of the object therefore depends not only on how large
the difference in attenuation is between the object and its
surroundings, but also on how large this signal difference is
compared to the uncertainty in the signal, i.e., SNR.
The number of x-ray quanta detected in some time inter-
val follows Poisson counting statistics. For a Poisson pro-
cess, the variance in the number of detected x-ray quanta is
equal to the mean number of detected photons. Therefore, if
the mean fluences are known, a signal-to-noise ratio can be
calculated. The signal-to-noise ratio of the bone signal
shown in Fig. 1 is calculated as
SNR5
image signal
noise 5
fp22fp1
A~fp21fp112fs!/2
. ~3!
Rewriting in terms of the geometry shown in Fig. 1, we
obtain
SNR5AAf iTh
2~12e2D!
A11e2D1 2SF
12SF
, ~4!
where A is the area of the detector element, f i is the incident
fluence, T is the patient transmission, and h is the x-ray
detector efficiency. Equation ~4! shows that the SNR, like the
contrast, decreases as the difference in attenuation between
the object and the background ~D! decreases. However, un-
like the contrast, the SNR is proportional to the number of x
rays detected (Af iTh5the area3fluence3transmission
3collection efficiency5number of detectedx rays!. In addi-
tion, scatter reduces the SNR by adding noise without con-
tributing to the signal.
The SNR versus x-ray energy for an image of a 1-cm-
thick bone in 20 cm of tissue can be calculated using Eq. ~4!.
A typical diagnostic imaging procedure delivers a dose of
0.05 cGy ~50 mR! to the patient.31 For the same patient dose
at megavoltage energies, the SNR would be ; 100 times
smaller. While the diagnostic SNR would satisfy Rose’s cri-
teria for visibility (SNR55),30 the megavoltage beam would
not ~Table I!. However for the same photon fluence, a mega-
voltage beam delivers more dose. Doses more common in
megavoltage imaging are also shown in Table I.
This simple model demonstrates that subject contrast de-
creases with increasing x-ray energy. Not only does the con-
trast of objects decrease, the rate of decrease depends on the
effective atomic number of the object. This results in the
contrast of air passages exceeding that of bony anatomyMedical Physics, Vol. 28, No. 5, May 2001when x-ray energy exceeds 100 keV. Furthermore, the SNR
of the bone signal decreases rapidly with increasing energy.
For the same dose to the patient, the SNR is much lower at
megavoltage energies ~2 MeV! than that at diagnostic ener-
gies ~50 keV!. For typical diagnostic and therapy doses of
0.05 and 10 cGy, respectively, the gap in SNRs is reduced.
The SNR is only five times lower at megavoltage energies.
2. Quantum efficiency
While quantum noise affects image quality, the efficiency
of propagating the quanta through to the final detection stage
can have a large impact on the SNR. An analysis of the
detective quantum efficiency ~DQE! of an imaging system
determines the magnitude of this effect. While a thorough
introduction in DQE is beyond the scope of this report ~see,
e.g., Ref. 32!, a brief example of the impact of DQE on the
design of one component of the imaging chain is presented.
The DQE is a measure of how efficient the imaging system is
at transferring the information contained in the radiation
beam incident upon the detector. This is expressed as the
square of the ratio of SNR output to SNR input as a function
of spatial frequency.
The image receptor should always have high quantum ef-
ficiency so that a large fraction of the incident x-ray quanta
actually will interact in the receptor. In reality, portal imag-
ing generally operates with low quantum efficiency. All
commercial portal imaging systems use a metal plate ~x-ray
converter! to convert photons to Compton electrons. In
video-based EPIDs, a phosphor screen is used to convert the
electrons into optical photons. A scanning liquid ion cham-
ber directly detects ionization due to the electrons. While
;4% of the incident x-ray quanta interact in the metal plate,
less than 1% of the incident x-ray quanta will generate elec-
trons that exit from the metal plate, propagating quanta fur-
ther down the imaging chain. Figure 2 shows the quantum
efficiency of a 1 mm copper plate in contact with different
thickness of phosphor screens, when irradiated by a 2 MeV
x-ray beam ~calculated using the EGS4 Monte Carlo code!.
Conventional portal film, exposed under a metal plate, with
no phosphor, has a quantum efficiency of ;1%.
Figure 2 shows that the quantum efficiency increases as
the thickness of the phosphor screen increases, because the
incident x-ray quanta can also interact directly within the
phosphor screen.33 Therefore, somewhat fortuitously, the
need for a phosphor screen increases the quantum efficiency
of commercial EPIDs. For example, a phosphor screen thick-
ness of 200 mg/cm2 ~in a camera-based EPID! has a quantum
efficiency ;2.5 times greater than the conventional cassettes
TABLE I. Calculated SNR and patient doses at diagnostic and therapeutic
x-ray energies.
Energy
Diagnostic
~50 keV!
Therapeutic
~2 MeV!
Therapeutic
~2 MeV!
Therapeutic
~2 MeV!
Therapeutic
~2 MeV!
Patient
dose
0.05 cGy 0.05 cGy 1 cGy 10 cGy 55 cGy
SNR 71 ,1 4.8 15 35
716 Herman et al.: TG58 716used for portal films. A similar argument can be made for the
liquid in the scanning ion chamber systems, with a thickness
of ;80 mg/cm2, yielding a quantum efficiency of 1.5 relative
to film.
Direct approaches to increase quantum efficiency by in-
creasing the thickness and/or density of the metal plate x-ray
detectors are often ineffective. Typically, spatial resolution
deteriorates due to the increased extent of the x-ray deposi-
tion region. For the commercial camera-based EPIDs, thick
phosphor screens are often employed. In addition to the loss
of spatial resolution and optical light transmission, thick
screens are prone to nonuniformity in phosphor content, and
thus add to the structure noise of the imaging system. It is
unlikely that increasing the thickness of the phosphor screens
will yield further benefits.
3. Other sources of noise
The above-given analysis of SNR and quantum efficiency
is based on primary x-ray quantum noise only and does not
include other sources of noise, each of which can have a
major effect on the image quality. There are a large number
of other noise sources in any portal imaging system, includ-
ing energy absorption noise,34 noise added by the imaging
system, and noise in the human visual system.
Note that the small amount of information from the x-ray
beam extracted by all EPIDs and portal films still represents
a very large amount of detected x-ray quanta. Indeed, at typi-
cal exposure ~or dose! used for imaging, the x-ray fluence
reaching the image receptor is generally 100 times greater at
megavoltage energies than at kilovoltage energies.35 It ap-
pears that poor image quality is not because the image recep-
tors do not have enough x-ray quanta interacting in them, but
because the image receptors either add additional noise to the
images or display the images so that noise in the eye–brain
system becomes important.
Measurements of Munro et al.36–38 suggest that conven-
tional portal films record more information than EPIDs, but
FIG. 2. The percentage of incident x-ray quanta that deposit energy in the
phosphor layer of an x-ray detector consisting of a 1 mm copper plate and
different thicknesses of Gd2O2S phosphor screens. The ‘‘phosphor ~indi-
rect!’’ curve represents those quanta that first interact in the copper plate and
deposit energy in the phosphor screen. The ‘‘lost in metal’’ curve represents
those quanta that interact in the metal plate but do not deposit energy in the
phosphor screen. These quanta do not contribute to the image. As the phos-
phor thickness increases the number of x-ray quanta that deposit energy
directly in the phosphor layer also increases.Medical Physics, Vol. 28, No. 5, May 2001the experience of EPID users and contrast-detail studies39
suggest that improved display of portal images by EPIDs
reduces the effect of observer noise40 inherent in visual film
observation. This is due to the superior contrast resolution of
the EPID and the ability to process the images and more than
compensates for the smaller information content.
The ideal image receptor would be an EPID or film that
adds no electronic or film noise to the image and which
displays the image optimally. Recent developments, such as
EC-L film and amorphous silicon EPIDs, come close to
meeting this ideal. Figures 3~a!–3~f! show a series of simu-
lated images to demonstrate visually the effect that noise can
have on the appearance of x-ray images. Figure 3~b! shows
the ideal detector where the noise of the image of the objects
in Fig. 3~a! is due to the statistical variation of the x-ray
quanta. The change in image quality from Fig. 3~c! to Fig.
3~d! shows the effect of energy absorption noise. The change
in image quality from Fig. 3~d! to Fig. 3~e! shows the effect
of noise added by the imaging system. The further change in
image quality in Fig. 3~f! shows the effect of noise from the
human visual system. The amount of noise added by each
stage of the imaging system is representative of a typical
video-based EPID.
FIG. 3. Images calculated for various stages of the image acquisition pro-
cess: ~a! represents the input image, ~b! the image that would be generated
using all the incident x-ray quanta, ~c! the image that would be generated
using the x-ray quanta detected by the image receptor, ~d! the image that
would be generated after accounting for energy absorption noise, and ~e!
and ~f! the addition of noise by the image receptor. The additive noise
increased the variance in ~e! by a factor of 4 and that in ~f! by a factor of 9.
717 Herman et al.: TG58 717C. Spatial resolution
Another important factor that influences image quality,
but which is not included in the above-described model, is
spatial resolution. Spatial resolution is a measure of how the
image signal is blurred by the imaging system. For example,
the spatial resolution of the system influences how well
edges, such as those resulting from bones, will be detected.
The spatial resolution of commercial EPIDs depends on fac-
tors that are common to all EPIDs as well as factors that are
device specific. The spread of high energy particles in the
metal plate is common to all commercial EPIDs and is quite
modest.41,42 In addition to the lateral migration of high en-
ergy electrons, other processes such as x-ray scatter, brems-
strahlung, and positron annihilation, also contribute to the
signal spread in the metal plate.33,36,42 Once the high energy
particles exit from the metal plate they can spread in the
convertor ~phosphor screen, ionizing fluid!. While lateral
electron migration would be greater in the ionizing fluid
~;0.8 g/cm3! than in the phosphor screen ~;3.74 g/cm3!, it
is light spread in the phosphor screen36 that mostly deter-
mines the spatial resolution for the camera-based EPIDs.
Pixel size is the primary factor that determines the spatial
resolution for the matrix ion chamber EPID.43
The spatial resolution of an imaging system is often char-
acterized by examining how well the system reproduces a
point object ~infinitesimally small!. Acquiring an image of
such a point object measures the system’s point spread func-
tion. Conventionally, this spread of signal is represented in
the form of the modulation transfer function ~MTF!. The
MTF describes how well the system passes different spatial
frequencies and is calculated from the Fourier transform of
the point spread function. Any complete characterization of
an imaging system requires an examination of both the
signal-to-noise characteristics and the spatial frequency re-
sponse of the system.
It is a common misconception that the spatial resolution
of the imaging system is the major factor limiting the image
quality of portal films and portal images. Spatial resolution
of any portal image depends upon three quantities, the size of
the x-ray source, the spatial resolution of the image receptor,
and image magnification. Source sizes of medical linear ac-
celerators have been measured to be ;1 mm full width at
half maximum, or smaller. Other measurements have shown
that the line-spread functions for camera-based EPIDs are
0.8–1.0 mm36,44 full width at half maximum while that for
the matrix ion chamber EPID is 1.5–2.0 mm.43 Image mag-
nification is variable and can have an important effect on the
spatial resolution of the system. As the magnification in-
creases, geometric blurring due to the x-ray source increases,
while the size of the patient anatomy projected at the plane
of the image receptor also increases, reducing the effect of
blurring by the image receptor. Thus, there is an optimal
image magnification where the blurring due to both the im-
age receptor and the x-ray source is minimized. Calculations
suggest that the optimal image magnification is between 1.3
and 2.0, which fortunately encompasses the range of opera-
tion for almost all commercial EPIDs.45,46Medical Physics, Vol. 28, No. 5, May 2001Finally, in portal imaging, it is important to recognize that
there is reduced attenuation at megavoltage energy ~com-
pared with kilovoltage!, which results in the reduced sharp-
ness of the object and an apparent change in the projected
object dimension. This leads to the perception that portal
images have lower spatial resolution than diagnostic images.
Care must be taken when comparing images acquired with
different photon energies.
D. X-ray scatter
Scattered x rays, or any ‘‘nonprimary’’ photons, can re-
duce the subject contrast and the signal-to-noise ratio of por-
tal images ~see Fig. 1! by generating signals in the image
receptor that carry no geometric information about the pa-
tient’s anatomy but that add noise to the images. The reduc-
tion of contrast by x-ray scatter is of serious concern for
portal films, since the display contrast of film cannot be ad-
justed to compensate for any reduction in subject contrast.
For EPIDs, the reduction in signal-to-noise ratio due to x-ray
scatter is more important than the reduction in contrast.
While x-ray scatter has long been a major concern in kilo-
voltage x-ray imaging, it has been shown that it is much less
of a problem for megavoltage portal imaging.45,47 As the
energy of the x-ray beam increases, the scatter fraction ~the
fraction of the total fluence reaching the image receptor that
is due to scattered x rays! decreases from 0.9 at 100 keV to
less than 0.6 at 6 MV ~at the exit surface of the patient!. ~On
the other hand, the scattered component of kilovoltage beams
can be reduced substantially using grids, which is not pos-
sible for megavoltage beams.! As in diagnostic radiology,
geometric factors are quite important in influencing the scat-
ter fluence reaching the image receptor at megavoltage ener-
gies. The scatter fraction increases as the patient thickness
increases, as the field size increases, and as the air gap be-
tween the patient and the image receptor decreases. Apart
from extreme situations such as very large patient thick-
nesses and field sizes, and small air gaps, x-ray scatter gen-
erally does not degrade the image quality of portal image
significantly. Jaffray et al. have shown, using Monte Carlo
calculations, that the signal-to-noise ratio would improve by
less than 10% if all x-ray scatter were eliminated before
reaching the image receptor when a moderately thick ~20
cm! patient is irradiated.47
III. THE TECHNOLOGY OF MEGAVOLTAGE
IMAGING
Many different EPIDs have been examined since the early
1980s as alternatives to film for megavoltage imaging. Read-
ers are referred to four comprehensive reviews of portal im-
aging devices for further details.48–51 The following discus-
sion on EPIDs will concentrate on features of the matrix ion
chamber and the camera-based EPIDs, which are both avail-
able commercially. Promising new systems based on active
matrix flat panel imaging ~AMFPI! technology will become
available commercially in the near future and are detailed in
the literature.52–61 The new AMFPI systems will perform as
well as or better than the EPID systems described here.
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The matrix ion chamber device ~originally developed by
Meertens, van Herk and their colleagues! consists of two sets
of electrodes that are oriented perpendicularly to each other
separated by a 0.8 mm gap, which is filled with a fluid
~2,2,4-trimethylpentane! that is ionized when the device is
irradiated.62 Each set of electrodes consists of 256 wires
spaced 1.27 mm apart to provide an active area of 32.5 cm
on a side. One set of electrodes is connected to 256 electrom-
eters and the other set of electrodes is connected to a high-
voltage supply that can apply a 300 V potential to each elec-
trode individually. The matrix ion chamber array is read out
by applying a high voltage to each of the high-voltage elec-
trodes in succession ~for approximately 20 ms! and measur-
ing the signal generated in each of the 256 signal electrodes.
This procedure takes 5.5 s to read out an image. In addition,
a fast ~lower resolution! scanning mode is available that
scans the array in 1.5 s by applying the high voltage for a 10
ms period to two high voltage electrodes at a time. The fast
acquisition mode is useful for acquiring double-exposure im-
ages. The more recent systems operates with a high voltage
bias of 500 V and at rate of 5 ms readout per electrode giving
an entire image read out time of 1.25 s.
The most obvious advantage of the matrix ion chamber is
its compact size, which makes the device a convenient re-
placement for film cassettes. Another advantage is its geo-
metric reliability—images acquired with the system have no
geometric distortions. The major limitation of a scanning ra-
diation detector is quantum utilization, since only one high-
voltage electrode ~out of 256! is active at any one time.
However, the physics of signal generation in the 2,2,4-
trimethylpentane improves the quantum utilization of the
matrix ion chamber considerably. The signal measured by
the matrix ion chamber depends on the rate of formation and
the rate of recombination of the ion pairs that are generated
in the ionizing fluid. Even when no high voltage is applied to
FIG. 4. The relative ion-pair concentration in the matrix ion chamber as a
function of irradiation time—in the absence of high voltage. The ion-pair
concentration builds up to a maximum value in 0.3–0.5 s and does not
change with increasing irradiation time. The equilibrium concentration de-
pends on dose rate. The horizontal arrow represents the signal that would be
measured in a 10 ms period ~the typical time that high voltage is applied to
a high voltage electrode! if no charge integration occurred in the ionizing
fluid.Medical Physics, Vol. 28, No. 5, May 2001the electrodes, the rate of recombination of the ion pairs
generated in the 2, 2, 4 trimethylpentane is relatively slow.
Therefore, the concentration of ion pairs can increase over a
period of time until an equilibrium is reached between ion-
pair formation, and is a function of the dose rate at the matrix
ion chamber and ion-pair recombination, the latter is propor-
tional to the square of the ion-pair concentration. The rate of
ion-pair formation as a function of irradiation time in the
absence of high voltage bias is shown in Fig. 4.
In effect, the signal measured by any electrode of the
matrix ion chamber does not depend greatly on the dose rate
during the 5–20 ms period when the high voltage is applied
but on the previous irradiation history of the electrode. How-
ever, the effective period of the charge integration ~0.5 s! is
still short compared with the total image acquisition time.
Therefore, a large fraction of the radiation that interacts with
the matrix ion chamber does not generate any measurable
signal. For this reason, the matrix ion chamber requires
higher doses to generate images than other portal imaging
devices. Note that once the latent image has been formed, the
more rapidly that the image can be read out, the smaller the
dose to the patient required to form an image.
An example of a lateral neck image acquired with the
matrix ion chamber EPID is shown in Fig. 5. Since spurious
~dark! signals can be generated in the electrometers and ion
chambers, and because the sensitivities of each ion chamber
can vary, the raw signals from the matrix ion chamber EPID
must be processed before yielding a usable image. For simi-
lar reasons, calibration of the system on a monthly basis
ensures its optimal operation. Because the matrix ion cham-
ber is a scanning EPID, it is susceptible to artifacts if the
dose rate of the accelerator changes during image acquisi-
tion. Thus, the radiation beam has to stabilize for some pe-
FIG. 5. ~a! Raw image from a matrix ion chamber EPID. ~b! Dark field
image from this EPID. The signals are mostly caused by transients of the
high voltage switching. ~c! Flood field image from this EPID. The vertical
lines are due to differences in sensitivity of the amplifiers. ~d! Fully cor-
rected image ~single frame at 1.7 s 4 MV 250 MU/min!.
719 Herman et al.: TG58 719FIG. 6. ~a! Fitted presampling line
spread functions ~LSF!, normalized on
the central value. ~b! Modulation
transfer functions ~MTF!. The poorer
vertical resolution may be caused by
the relatively low speed of the elec-
trometer amplifiers and the shape of
the electric field in the chamber.riod ~typically 1.0 s! after start-up before image acquisition
can begin. The best image quality results when the scanning
of the high-voltage electrodes is synchronized with the puls-
ing of the linear accelerator. In practice, the matrix ion cham-
ber EPID needs to be calibrated for each of the dose rates of
the accelerator that will be used clinically. Finally, many of
the radiation sensitive readout electronics are located imme-
diately adjacent to the active region of the matrix ion cham-
ber. Even with the use of electronic components that have
improved resistance to radiation damage, care must be used
to ensure that the field size or the position of the EPID is
coordinated to prevent accidental irradiation of the
electronics.63
Van Herk et al. have characterized the MTF and DQE of
the system by correcting for the nonlinear response of the
system. Figures 6~a! and 6~b! show the fitted presample line
spread function and the corresponding MTF of the latest ma-
trix ion chamber EPID. Horizontal and vertical directions are
with respect to the image detector. The detector has a high
sensitivity all the way up to the Nyquist frequency. Two
effects may cause the significant difference between the hori-
zontal and vertical resolution. First, the 256-electrometer am-
plifiers include a filter with a time constant of about 1 ms,
which may cause some blurring in the vertical direction. Sec-
ond, the absence of shielding between the ionization cham-
bers may cause some spurious sensitivity outside the pixel
area due to the direction of the electric field lines.
The zero-frequency DQE depends strongly on the dose
per image ~Fig. 7!. In contrast to linear detectors, where the
FIG. 7. Detective quantum efficiency ~DQE! and sampling efficiency of the
matrix ionization chamber device.Medical Physics, Vol. 28, No. 5, May 2001DQE decreases with decreasing dose ~due to the influence of
system noise!, the DQE increases for this detector. This ef-
fect is caused by the increase in integration time at lower
dose rates due to the latent image in the liquid. The ratio
between the DQE and the sampling efficiency gives the in-
herent efficiency of the metal plate detector, which would be
reached at 100% sampling efficiency. Decreasing the readout
time ~which improves the sampling efficiency! may therefore
further improve the DQE. Efforts are being made to further
characterize the frequency dependence of the DQE for the
matrix ion chamber EPID.
In addition to the detection electronics, a typical liquid ion
chamber EPID has a gantry mounted robotic arm that pro-
vides complete retraction of the unit.
B. Camera-based EPIDs
Camera-based systems consist of a metal plate and a
phosphor @gadolinium oxysulfide (Gd2O2S)# screen viewed
by a camera using a 45° mirror. When irradiated, high-
energy electrons generated in the metal plate and the phos-
phor screen are converted into light in the phosphor screen
and this light creates the video signal generated by the cam-
era. The video signal from the camera can be digitized and
the digitized image can be viewed on a monitor located in
the control area of the accelerator. The video systems differ
primarily in the deployment of their housing assembly ~see
Table II! and camera operation. Various techniques for read-
out are designed to reduce the impact of noise in the imaging
chain.
Video EPIDs suffer from the major limitation of light
collection efficiency of the optical chain. Since the light is
highly scattered within the phosphor screen, the light is emit-
ted from the rear of the screen in all directions with equal
probability. Only those light photons that are emitted within
a small cone subtended by the lens of the camera can gener-
ate a signal in the camera; typically only 0.1%–0.01% of the
light emitted by the phosphor screen reaches the camera.
This poor light collection efficiency reduces image quality in
two ways. First, if an x-ray photon interacts in the x-ray
detector but none of the light generated by this interaction
reaches the camera, then no measurable signal is produced.
720 Herman et al.: TG58 720TABLE II. Features of the five commercially available EPIDs.
Supplier Elekta-Philips Eliav Infimeda Siemens Varian
Name SRI 100 PortPro Theraview Beamview Plus PortalVision
Type CCD camera CCD camera Plumbicon camera Newvicon camera Matrix ion chamber
Detector pixels 5123512 5123512 5123512 5123512 2563256
Digitization 8 bit frame-grabber 8 bit frame-grabber 8 bit frame-grabber 8 bit frame-grabber 14 bit A/D converter
Max frequency
of acquisition
7 frames/s 30 frames/s 2 monitor units 30 frames/s Mark 1: 5.5 s
Mark 2: 1.25 s
X-ray detector 1.5 mm steel plate 1.5 mm steel plate 1.5 mm brass plate 1.2 mm brass plate 1.0 mm platoferrite plate
1411 mg/cm2
Gd2O2S screen
1411 mg/cm2
Gd2O2S screen
1400 mg/cm2
Gd2O2S screen
1160 mg/cm2
Gd2O2S screen
10.8 mm 2.24-trimethyl-pentane
1 wire electrodes
Mechanical
assembly
Dismountable Portable Partly retractable and
partly dismountable
Fully retractable Fully retractable; portable
if used with retractable arm
Mounting Philips only Any accelerator Any accelerator ~GE,
Varian, Scanditronix!
Siemens only Any accelerator ~attached by customer!
Collision
interlock
Yes No Yes ~connect to
accelerator motion
interlocks!
No ~interlock
activated during
deployment only!
Yes
Field of view
at isocenter
(cm3cm)
Fixed
19324
Variable Adjustable
31.8 diam Varian
31.5 diam Sanditronix
31.6 diam G.E.
Fixed
24330
Adjustable
25325
Detector area
(cm3cm)
30338 Variable 40340 ~detector! 35344 ~detector! 32.5332.5 ~detector!
Detector to
isocenter ~cm!
60 Not applicable 30–60 ~Varian!
26–67 ~G.E.!
27–78 ~Scanditronix!
39 5–80
Display center
accuracy
61 mm 65 mm 62 mm 65 mm
Prototype
descriptions
Ref. 49 Ref. 51 Ref. 53 Refs. 46,47
Resolution
lp/mm ~Sec. IV!
0.180 0.305 0.223 0.204 0.258
aThe Infimed system is now marketed by Cablon Medical.Second, if only a small signal is produced in the camera, then
noise generated by the preamplifier and other electronics of
the camera may be large compared to the signal. As a result,
the development of commercial camera-based EPIDs has fo-
cused on increasing light collection of the optical chain by
increasing the thickness of the phosphor screen to increase
the light output and to a smaller extent increase the x-ray
quantum efficiency,39,44 and using a large aperture lens that
collects more of the light.39,49
The use of large aperture lenses suffers from decreased
spatial resolution because of spherical aberrations ~light rays
reaching the edges of the lens do not focus to the same point
as those reaching the center!. The spatial resolution of theseMedical Physics, Vol. 28, No. 5, May 2001lenses decreases from the center to the edge of the lens.
There is also a reduced depth of field which renders the focal
distance more sensitive to optical wavelength. Large aperture
lenses also suffer from vignetting, which results in images
that are brighter at the center of the lens than the edge. This
change in image brightness is corrected through software or
hardware schemes. Finally, large aperture lenses can gener-
ate distortions, such as pin cushion or barrel distortion,
which cause straight lines to appear curved in the image,
especially at the edges of the field of view. Examples of the
MTF and zero frequency DQE of a camera-based EPID from
camera-based system are shown in Fig. 8. An image acquired
with two-monitor units at 6 MV with this system is shown inFIG. 8. ~a! MTF, video EPID, ~b! dQE,
video EPID.
721 Herman et al.: TG58 721Fig. 9. Image 9~a! was corrected for lens vignetting, while
image 9~b! shows improvement from simple image enhance-
ment tools such as level and window and contrast adjust-
ment.
There are a variety of mounting systems for video-based
EPIDs that range from rigid gantry mounts, partially or com-
pletely retractable systems to systems independent of the
gantry on a portable stand.
IV. COMMISSIONING AND QUALITY ASSURANCE
FOR EPIDs
A. Installation and commissioning
At the time of installation/acceptance the following fea-
tures must be verified: mechanical and electrical safety, geo-
metric reproducibility, image quality, and software perfor-
mance specifications. Following acceptance, commissioning
will characterize operational features relevant to clinical use
and specifications for routine quality assurance. The items
discussed in detail here are summarized in Table III.
Some elementary safety aspects of EPID should always
be checked, even if the devices are not used regularly. While
FIG. 9. Video EPID image ~a! and ~b! with enhancement.Medical Physics, Vol. 28, No. 5, May 2001one should adhere to the manufacturer’s maintenance
manual, if available, the following list contains a few of the
basic tests that should be considered.
~a! Mechanical stability and integrity of EPID mounting
and casing. The most serious risk is dropping the device on a
patient or therapist during gantry rotation. Particular atten-
tion should be placed on checking the mounting point for
detachable EPIDs and gears for retractable or movable
EPIDs.
~b! Operation of collision detection system. The most se-
rious potential hazard is the EPID colliding with the patient.
~c! Electrical insulation/grounding. The most serious po-
tential hazard is potential electrocution of patient or staff.
Most systems are grounded through the power outlet con-
nected to the control computer and/or interface unit. The
power supply insulation must be checked. One should also
examine the cabling to the detector. The Varian PortalVision
Mark 1 carries 300 V to a plug-on detector cassette ~but the
improved Mark 2 generates the applied 500 V internally
from the 115 V on the cable!. Any moving cable or cables
that potentially reach the patient or staff should be inspected
visually once a month.
The Varian PortalVision detector contains a volatile liquid.
In case of a collision, the device should be powered off and
should be checked for any damage to the detector array.
However, such damage is relatively unlikely since the actual
array is under 2 cm of Styrofoam. Leakage of the liquid can
be identified by a large change of the sensitivity of the cen-
tral part of the detector. In such a case, the detector should be
removed from service.
1. Dose control
Optimizing the dose necessary for imaging is important
and varies by application and EPID. Improper dose control
could cause failure to complete acquisition of a useful veri-
fication image in the preset dose ~resulting in a useless image
and extra dose required for obtaining a subsequent image!,
and over-dosage due to a failed beam-off signal. Most EPIDsTABLE III. Summary of initial commissioning items, tolerances and methods.
Item Purpose Tolerance Method/tools
Mechanical stability Safety No accidental crash Inspection
Image quality Optical/physical alignment ~2 mm! Optical test pattern
Optical distance indicators
Electrical connections Safety No exposed connections/wires Inspection of cabling/grounds
Calibration Image quality Acceptable flat field, dark current/noise characteristics Per vendor follow calibration steps for energy,
field size, and noise. Vendor specifications vary.
Dose control Image quality/Safety Preset dose ~linac! control functions Program and verify correct beam termination
with dose.
Image quality Image quality Acceptable contrast ~1%!
and spatial resolution ~2–3 mm!
Las Vegas phantom, other contrast phantoms,
imaged at each energy
Analysis software Quantitative reporting Reported measurement within tolerance
of 3 mm and 2 deg. Edge detection matches
field boundary
Set up known error conditions and verify system
reporting and field edge definition under varying
field acquisition conditions
722 Herman et al.: TG58 722have adjustable trigger levels or delay times to allow the
accelerator output to become stable.5,6 The dose delivered for
a localization image can be preset in three ways: by manual
beam interruption ~not preferred, since operator errors might
lead to a large dose!, by a preset dose, or by auto-beam off.
One should test correct image acquisition with different at-
tenuators or an anthropomorphic phantom in the beam. Re-
ducing the dose required for localization images is possible
in video systems by using short exposure times ~with some
reduction in image quality!, but the PortalVision has a pre-
determined acquisition time. For the latter, the use of a low
dose rate is desirable. A complete test of the EPID-linear
accelerator control system including the information system,
which may contain parameters that are downloaded to the
EPID or linac, must be performed prior to clinical use.
2. Calibration
Most EPID systems require some form of image calibra-
tion. Calibration provides correction factors and measures
accelerator and EPID characteristics that are used to produce
the highest quality image in routine use. Often, background
signals are subtracted and inhomogeneity of response as well
as linear accelerator beam characteristics are divided out.
One should be aware that noise in the calibration images can
reduce clinical image quality and should be minimized. The
EPID must be calibrated for the varying conditions of clini-
cal image acquisition. Calibration procedures depend on the
type of EPID and vendor recommendations, however in each
case it involves exposing the EPID to radiation under spe-
cific conditions. Calibration usually includes measurement of
a dark current or noise image. This is acquired with no beam
and represents signal present in the EPID when there is no
radiation beam. This is followed by the acquisition of a full
open field. The open field image is used to correct for repro-
ducible treatment field specific characteristics, such as varia-
tion of intensity across a beam profile. Since beam charac-
teristics may be beam energy and field size dependent,
calibrations at various energies and field sizes must also be
made. The information is used to generate correction factors
used in the image acquisition process. In some cases, scatter
and attenuation introduced by the patient can affect image
quality and patient thickness and detector distance are there-
fore considered calibration parameters. The EPID may even
require gantry angle calibration, if the mechanical stability of
the EPID is such that a mechanical shift offsets the calibra-
tion of a flat field, or the treatment machine characteristics
change significantly at varied gantry angles. The user is en-
couraged to determine which characteristics are most impor-
tant for the EPID chosen, to ensure optimal operation.
Test image acquisition should be performed using the
fresh calibration to ensure absence of artifacts due to accel-
erator instability or objects in the beam. While table grids
and patient supporting plates appear as distractors in images,
they are never sufficiently stable to be removed by calibra-
tion. The frequency of recalibration depends on the measured
stability of image performance. Typically, a monthly recali-
bration may be necessary depending on the mechanical sta-Medical Physics, Vol. 28, No. 5, May 2001bility of the device. If any of the optical components in a
fluoroscopic system are altered, a recalibration is recom-
mended.
3. Linearity
The linearity of imaging geometry should be established
during commissioning. Spatial distortions must be character-
ized or removed from EPID images before they can be used
for quantitative portal imaging. Lack of rigidity in EPID
components of video systems may result in instability of
magnification or spatial linearity. EPID systems that use an
analog video camera are susceptible to distortions due to
variations in magnetic field and may depend on gantry angle.
Bending or displacement of mirrors or front screens may also
cause distortions. Simple mechanical phantoms ~square grid
of pins! to test for distortions are available from the manu-
facturer or easily fabricated.64,65 The use of fiducial markers
or field edges to quantify patient setup errors can eliminate
mechanical instability effects.
The reproducibility is established by checking both posi-
tion ~location and orientation of projected collimator axes!
and linearity as the imager is repeatedly repositioned. This
should also be performed at various gantry angles.
4. Image quality
Clinical image quality commissioning is based on spatial
resolution and contrast resolution. All present day EPIDs
provide 1% or better contrast resolution for larger objects
~.5 mm!. These characteristics are sufficient to perform por-
tal localization on most radiotherapy fields. The Las Vegas
phantom ~Fig. 10! has been used in acceptance testing and
continuing QA. It is composed of varying thickness and
varying width holes embedded in aluminum which represent
spatial and contrast resolution benchmarks. Visualizing a
certain hole implies a specific resolution for a given linear
accelerator/EPID combination. Properly setup EPIDs will
typically be able to resolve the 17 shaded holes in Fig. 10.
Most should be able to resolve another four marked with
X’s. AMFPI systems should be able to resolve all the holes.
Shalev and colleagues have introduced a phantom and soft-
FIG. 10. Aluminum Las Vegas phantom for EPID image contrast and spatial
resolution.
723 Herman et al.: TG58 723ware tool that allows the user to quantify EPID spatial reso-
lution and contrast-to-noise ratio ~CNR!.66 The software de-
termines CNR and spatial resolution from images acquired
of a standardized phantom. The resolution and noise values
reported may be used as baseline values for acceptance test-
ing and ongoing QA of the EPID. The user is encouraged to
demand this type of quality test at acceptance to help guar-
antee that the EPID is indeed operating at or above specifi-
cations. The spatial resolution indicated in the final row of
Table II represents the spatial resolution ~in line pairs per
mm! for commercial EPID configurations as determined us-
ing this phantom and analysis tool.66 A value of 0.25 indi-
cates 2 mm spatial resolution. Regardless of which phantom
is used and whether quantitative software is applied, the ini-
tial images represent baseline data for continuing quality as-
surance of the EPID. These should be the best images the
system can obtain. In addition, images of anthropomorphic
phantoms ~phantoms used in a diagnostic radiology depart-
ment may be better for this purpose than a sliced RANDO
phantom! should be stored to represent the operation of the
imager at optimum image quality.
5. Software
Commissioning of software involves testing of features
such as EPID/linac control, network connections, storage,
archival/retrieval and backup ~including compression
schemes!, security functions, and analysis tools. During
commissioning, responsibilities for these operations should
be assigned.
If an EPID is intended for use in quantitative evaluation
of patient setup, commissioning should involve measurement
of known setup errors. These measurements should be de-
signed to separate the results into those based on field place-
ment and the location of the phantom in the field. The effects
of image processing ~e.g., image enhancement and edge de-
tection! on the accuracy of setup analysis should be estab-
lished. Image processing may affect the results of quantita-
tive reporting.67
The commissioning process should include understanding
and characterizing the limits of reference image generators
~simulators, DRRs, etc.!, since field placement errors are de-
termined by comparing portal images to reference images.
A test should be performed to determine the ability of the
system to reproduce a null transform on identical images. It
is best to use the EPID’s own software to compare an image
to itself. A number of users should be recruited to use the
setup verification tools to assess setup error on the image
pair. This also allows the determination of inter- and intra-
user variation in error detection, which should be established
before setting correction thresholds. Typical accuracy for
such tests have ranged from 0.5 to 2 mm.
A second procedure involves attempting to assess a
known transformation. In this case, a reference image of an
anthropomorphic phantom can be taken. This image can be
transformed by a known transformation, or the phantom can
be moved by a known amount and reimaged. The measured
transformation can then be compared to the expected trans-Medical Physics, Vol. 28, No. 5, May 2001formation. Objective assessment of alignment tools can also
be performed using a standard image data set.68
A complete dry run of a known phantom through the en-
tire treatment process ~CT/simulation, planning, reference
image generation, initial setup, imaging, and setup measure-
ment! allows testing of the proper operation of the EPID
system within the confines of department infrastructure. This
will allow identification of other potential sources of error,
such as laser calibration differences or limits in DRR reso-
lution. It is also advised to attempt to introduce errors into
the alignment by rotating the phantom up to 6 ° and by gen-
erating portal images of varying quality relative to a refer-
ence image. An accuracy of 63 mm and 61 ° should be
achievable. These tests should be performed for images ac-
quired at all four cardinal gantry angles. Dry run procedures
also help in training, education, and identifying individual
responsibilities. Furthermore, the amount of time necessary
for intended EPID use is indicated through dry runs.
B. Quality assurance
To maintain EPID performance, a quality assurance pro-
gram must be put in place. The program must define specific
measurements, frequencies, and tolerances ~Table IV!. Fig-
ure 11 shows examples of EPID QA daily and monthly
worksheets for a matrix ion-chamber system in clinical use.
The QA program should be in writing and records of the
completed tasks should be kept for review.
Frequent ~e.g., daily! quality assurance procedures in-
clude safety features such as mechanical integrity, collision
interlocks, etc. Operational and image checks are accom-
plished by imaging a fixed phantom in a fixed geometry with
a given dose. This allows rapid assessment of operability and
image quality.
TABLE IV. Frequency of QA tasks.
Interval
Task
~P—physicist, M—manufacturer, E—engineer,
T—therapist!
Daily Inspect imager housing ~T!
Test collision interlock ~T!
Acquire day’s first image during machine warm-up
procedure to verify operation and image quality ~T!
Verify sufficient data capacity for day’s images ~P or
designate!
Monthly Acquire image and inspect for artifacts ~P!
Perform constancy check of SNR, resolution and
localization ~P!
Review image quality
Perform image and disk maintenance ~P!
Mechanical inspection @latches, collision sensors, optical
components ~P,E!#
Electrical connections ~P,E!
Test collision interlock ~P!
Hardcopy output ~P!
Annual Perform full check of geometric localization accuracy ~P!
724 Herman et al.: TG58 724FIG. 11. ~a! Daily EPID QA worksheet sample; ~b1! and ~b2! monthly QA sample.Monthly QA includes detailed safety and mechanical in-
tegrity checks ~Table IV!. A review of daily QA results to
determine trends and degradation in image quality should be
performed. The interval for recalibration of the imager isMedical Physics, Vol. 28, No. 5, May 2001initially determined by the vendor and established at the time
of commissioning, and may be changed through observation
of trends in image quality. Periodic ~e.g., monthly! disk and
database maintenance should also be performed.
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727 Herman et al.: TG58 727A rapid check of software performance for quantitative
measurement should be performed on an annual basis. This
could involve a dry run using an anthropomorphic phantom,
or could be performed using a geometric phantom ~e.g., a
radiosurgery target ball placed in a known location in the
room coordinate system!. Software QA should also be per-
formed with upgrades and changes in the EPID system.
V. CLINICAL APPLICATION OF EPIDs
The primary applications of EPID include verification of
patient setup and assessment of target and organ motion.
Current research includes use of EPIDs for compensator de-
sign and verification, treatment machine QA, and patient do-
simetry.
A. Preparing for EPID implementation
Certain specific goals and protocols for the use of EPIDs
must be established before they can be successfully brought
into the clinic. Table V lists examples of questions that
should be discussed before EPID implementation. Table VI
shows estimates of physician, therapist, and physicist time to
implement a simple EPID program. It should be noted that
EPID use and responsibilities differ between clinics around
the world and between different EPIDs and these tables are
guides indicative of issues each clinical team should address.
B. Software tools
The complexity of EPID software has evolved over the
past decade in response to improved understanding of clini-
cal applications as well as flexibility of acquisition modes for
new EPID technology.
1. Image acquisition
A typical portal imaging system will have a user interface
that allows selection of different image acquisition modes.
Although the range of operating modes may vary, the fol-
lowing are commonly available on commercial EPIDs:
a. Single exposure (localization). In this mode of acqui-
sition, a single image is acquired for a short period of time
~typically at the start of the treatment!. The duration of the
exposure can either be controlled by a fixed time criterion or
by the time that the beam is on.
b. Verification image. Verification images can either be
an average of multiple images acquired during a period of
treatment, or single images acquired over a longer period of
time ~higher dose! than the localization images mentioned
previously.
c. Double exposure. This mode of operation is similar to
that of weekly portal film acquisition. One image is the
single exposure image, and the second is an ‘‘open field’’
image. Again, control of each image acquisition may be via
fixed time intervals or by the duration of the beam. Typi-
cally, the open field and portal images are combined using a
weighted sum to produce a single image. A field outline from
the portal can also be automatically extracted and overlaid on
the open field image.Medical Physics, Vol. 28, No. 5, May 2001d. Movie loops. The digital nature of the EPID allows
movie loops or on-line fluoroscopy to be acquired during
treatment. In some cases, all of the images mentioned previ-
ously are generated by summation of one or more images
acquired in a loop.
2. Image enhancement tools
Once an image has been acquired, unlike film, the image
data can be manipulated to improve landmark visibility and
image interpretation. Simple and sometimes automatic image
enhancement tools are available on all EPIDs, giving a major
advantage over film
One class of enhancement tools adjusts portal image con-
trast. The most basic of these, global contrast enhancement,
involves manipulation of the gray scale lookup table of the
video monitor displaying the image. The window and level
values determine what pixel values are displayed and the
range of video intensity values that these are mapped to. This
method is typically interfaced to the user by ‘‘slider’’ bars
adjacent to the image.
More advanced techniques employ nonlinear mappings of
pixel values within the image based on redistributing inten-
sity values to normalize the shape of the intensity histogram.
These histogram equalization techniques alter a pixel’s inten-
sity based on the global or local adaptive histogram equal-
ization ~AHE! distribution of intensity. A disadvantage of
AHE is the fact that the procedure is nonlinear, causing dis-
tortions of anatomical structures and field edges, which could
affect quantitative measurement.69,70
High pass filtering can also achieve feature enhancement
within a portal image, and can be performed by the convo-
lution of a filter kernel and image to produce the feature
enhanced image.71 Typical kernels include the Sobel ~first
derivative! and Laplacian ~second derivative of the image!
filters. A third known as an unsharp mask involves subtract-
ing a smoothed version of the image from the original, re-
moving all low frequency components.72 This processed im-
age is combined in a weighted sum with the unprocessed
image. Filtering can also be performed in the frequency do-
main by first calculating the Fourier transform of the image
and applying a filter function to the image.73 Calculating the
inverse transform of the result generates the filtered image.
A disadvantage of high pass filtering is the effect of noise
amplification caused by the operation of the high pass filter.
A compromise can be found by the application of a Weiner
filter that produces the most optimal reconstruction of the
image based on a least-squares minimization criterion.74
There is no single ‘‘best’’ enhancement scheme. Enhance-
ment schemes should be selected by the users for the sites
and image acquisition modes to be used clinically.
3. Setup verificationÕerror detection tools
Treatment setup verification can be divided into verifica-
tion of the geometric configuration of the treatment unit, and
verification of the patient and target position with respect to
the treatment geometry.
728 Herman et al.: TG58 728TABLE V. Questions that are pertinent to implement an EPID for clinical use.
Questions Options
1. What is the purpose/goal of installing EPIDs in the clinic? ~a! Simple film replacement/routine QA
~b! Accurate and efficient patient setup and repositioning
~c! Assess random and systematic errors in treatment
~d! Assessment of the efficacy of immobilization techniques
~e! Inter- and intrafraction motion studies
2. Which patients will EPID be used on for treatment verification? ~a! All patients?
~b! Special cases that are difficult to setup?
~c! Specific disease sites?
3. How will the EPID be used? ~a! Exclusively to eliminate film
~b! Combine with a predefined port film protocol
4. What is the frequency of imaging? ~a! Weekly
~b! Daily
~c! Dependent on site or patient
~d! Dependent on the statistics of setup error or decision rules
4a. What image acquisition modes are available on the EPID? ~a! Single exposure
~b! Double exposure
~c! Movie loops
5. What is the choice of reference image? ~a! Digitally reconstructed radiograph
~b! Conventional simulation film
~c! First approved EPID image
6. How will image evaluation be accomplished? ~a! Electronically, side by side on computer workstation
~b! Hard copy on conventional view box
6a. How many review stations are needed and at what locations? ~a! At each treatment machine
~b! Also in viewing rooms
~c! Also in physicians offices
7. When will you intervene/adjust setup? ~a! Threshold for corrective action
~b! On-line-intrafraction correction
~c! Off-line-interfraction correction
8. What image analysis protocol will be used? ~a! Visual inspection only
~b! Manual tools
~c! Semiautomated
~d! Automated
8a. Which analysis tools are available and validated on the system? ~a! Visual inspection only
~b! Manual tools
~c! Semiautomated
~d! Automated
9. How will physician approval be achieved? ~a! Signed hard copy off-line
~b! Electronic signature on-line
~c! Electronic signature off-line
9a. How will physician comments be communicated to others? ~a! Hard copy
~b! Electronic annotation within EPID/information system
~c! Electronic email outside of EPID/information system
10. What are the resources needed for storage, archival, and retrieval? ~A! Standalone hard disk
~b! Distributed database
10a. Is the system DICOM-RT compliant?
11. Implementation of a QA program ~a! Establish baseline mechanical limits and imaging quality
~b! Establish daily and monthly protocol
11a. What are the vendor established QA routines?
12. How will training and education for all users be scheduled? ~a! Establish training schedule
~b! Define personnel responsibilities
~c! Periodic in-service to ensure uniformly of clinical practiceMedical Physics, Vol. 28, No. 5, May 2001
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Medical Physics, VTABLE VI. Approximate personnel time commitments for various tasks related to the clinical use of an EPID.
Task Time per Personnel Comment
Acceptance testing 1–2 days Installation Additional
Education Expert 2 days1 Installation Physicist Per software
Therapist 1 day Installation Therapist
Physician 12 day Installation Physician Revision
Establish QA program 12 day Installation Physicist Plus ongoing
monitoring
Operation Imaging ,1–2 min Tx Field Therapist
Review 0–5 min Tx Field Physician/
Therapist
Depends critically
on mode of use—
Table V
QA Daily/
Weekly
3–5 min Week Therapist
Monthly 30 min Month Physicist
Quarterly 1–2 h Quarter Service
Commissioning Correction
Thresholds
1 month Protocol All Software, intra-
and interuser,
etc.Proper evaluation of treatment setup involves relating the
information in a portal image to that extracted from a refer-
ence ‘‘gold standard’’ of treatment setup. The gold standard
information can be a reference radiograph ~simulation film or
DRR!, features extracted from the reference image ~e.g., the
field border and the anatomic landmark information!, or
three-dimensional models of the patient ~e.g., CT data!.
Digital measurement tools such as digital rulers can de-
termine the distance from a given field border to critical pro-
jected anatomic interfaces. While not providing complete in-
formation on the nature of patient setup, such tools may be
used for rapidly assessing critical features of daily setup such
as field centering or spinal cord avoidance.
More detailed information about patient setup can be ac-
complished through the use of image registration algorithms.
These can be classified loosely by the general mechanism
used for selecting an optimal transformation.
Landmark-based techniques use geometric description of
landmarks to determine a transformation that aligns a refer-
ence and portal image. Landmark descriptions that have been
used include points, open curves, and drawn templates.
If points can be precisely localized, they can be aligned
with high precision. The major difficulty with the use of
point landmarks is the lack of suitable points. Observation of
typical radiographs indicates very few internal anatomic re-
gions that can be precisely localized as points on projections.
Projections of external fiducial marks have been used as
point landmarks, but these points may not properly reflect
patient setup errors. Implanted fiducials have also been in-
vestigated for use in reproducible setup of the head. It is
important to assess the reproducibility of selected point land-
marks.
A large number of anatomic landmarks can be described
adequately as open curve or line segments. A template-
matching algorithm allows a user to draw an arbitrary set ofol. 28, No. 5, May 2001landmarks on the reference image, and to determine an opti-
mal transformation for alignment by manually shifting these
landmarks until they are properly overlaid on the portal
image.75 This system can be very fast, permitting on-line use.
Other curve matching tools are more automated, providing
the optimal transformation by determining the transform that
best aligns overlapping curve segments.76
The use of landmark-based alignment algorithms requires
a trained user to spend time to identify landmarks for use in
alignment. Contrast-based algorithms show some promise
for fully automated alignment. Typically, the intensity distri-
bution in a region of a reference image is defined as a tem-
plate. Using cross-correlation techniques, the transformation
that optimally matches this template to a corresponding in-
tensity distribution in the portal image is found.
Such techniques have been implemented to align whole
images,77 and to select point landmarks based on the align-
ment of a series of small regions of interest containing dis-
tinct gray level distributions.78 An important consideration
for contrast-based alignment techniques is the source of ref-
erence and setup radiographs. In order for most contrast-
based algorithms to perform optimally, both images involved
should have similar contrast distributions. Simulator-
produced images have different contrast than portal images
due to the different absorption and scatter properties inherent
with different energies of radiation. Solutions to this problem
have been to establish a ‘‘gold standard’’ portal image at the
beginning of treatment, or to optimize the DRR generation
algorithms to produce contrast similar to that found in mega-
voltage radiographs.68,79
Modern image processing techniques take advantage of
the ability of computers to identify features in an image us-
ing properties similar to those a human observer is believed
to use. Gilhuijs and colleagues developed a procedure for
automated extraction of anatomic features and alignment to a
730 Herman et al.: TG58 730user-defined set of reference landmarks.80 In this procedure,
a top hat transformation was used to extract a set of candi-
date coordinates for locations of bone–soft tissue interfaces.
The optimal transformation that aligns the reference and por-
tal anatomy is determined by chamfer matching of these co-
ordinates with the distance space determined from the manu-
ally defined reference landmarks. Fritsch and colleagues
have made significant progress in the application of com-
puter vision techniques to the problem of image registration
in radiotherapy.81 Using the multiscale medial axis filter,
they have developed a system that extracts ‘‘cores’’ from
radiographs. These cores are three-dimensional descriptions
of features in images. Two of the dimensions are sued to
indicate the location of object ‘‘middles,’’ and the third de-
scribes the object’s width at the given location. Such features
have been evaluated for use in image alignment with prom-
ising results.80,81
Field edge detection is another important concern. There
are two reasons to find the radiation field on the image. As
most imagers do not maintain a rigid and reproducible rela-
tionship with respect to the central axis of the treatment unit,
the location of the radiation field can be used to establish a
coordinate system within which the variation of the location
of patient anatomy can be determined. In the absence of a
shaped radiation field, or when a field extends beyond the
borders of the image, a graticule projection may also serve
this purpose. A second important role for portal field border
extraction is verification of the shape and orientation of the
treatment portal.
A number of investigators have developed means of ex-
tracting the radiation field borders from portal images
automatically.82–84 The intensity histogram from a portal im-
age typically has two distinct peaks, representing the area
outside the radiation field, and the pixels within the field.
The range of pixel values between these peaks represents the
beam penumbra. A reasonable threshold can be extracted
automatically from this histogram to track the field borders.
When a field border is in air, or near a rapidly changing
density region of the patient, this technique may run into
difficulty. Bijhold and colleagues developed a tracking algo-
rithm that overcomes some of the limitations of threshold-
based field border extraction.82 McGee developed a system
to track the consistency of the field borders based on a model
FIG. 12. Clinical imaging protocols with an EPID for ~a! on-line and ~b!
off-line correction.Medical Physics, Vol. 28, No. 5, May 2001extracted from the initial treatment field. Wang and Fallone
have developed a mathematical model for local field penum-
bra extraction.85
One significant limitation of much of the setup error
analysis done to date is that the majority of clinical evalua-
tion tools are based on two-dimensional analysis of portal
images. An interactive procedure to quantify the setup varia-
tion of the patient in 3-D, based on fast computation of digi-
tally reconstructed radiographs ~DRRs! in two beam direc-
tions, has been developed. Computer aided comparison of
these DRRs with corresponding portal images produces pa-
tient setup error information in 3D.86–89
C. EPID clinical use
The types of errors detected include field and block shape
errors and field or patient placement errors. There are two
general methodologies in using an EPID for patient setup
verification and correction; on-line or off-line ~Fig. 12!. For
on-line correction, a pretreatment port can be acquired and
evaluated such that any setup error will be corrected before
the treatment continues. First day portal film localization is
an example of an on-line correction.
The most basic manifestation of off-line correction occurs
when the portal image is examined after treatment and, if
necessary, a correction is made at the following treatment
session. Standard weekly port films are an example of this
strategy. Off-line correction has also evolved into strategies
whereby multiple periodic images are evaluated to improve
statistical certainty for one or more corrections over an entire
treatment session.
1. EPID clinical protocol (step by step)
The following describes a simple procedure for using the
EPID in the clinic. ~1! For each patient, enter patient demo-
graphic, field data. Image acquisition data are also entered,
e.g., single or double exposure, movie-loop, etc. The type
and amount of data necessary varies depending on the EPID
manufacturer. If the EPID is part of an integrated informa-
tion system, much of the data input is done automatically
when the treatment course is initially setup. ~2! At treatment
time, the EPID is put into imaging position, the patient is
selected, the field is selected, and acquisition parameters
loaded. Again, if the EPID becomes more integrated into the
treatment system, the information system will automatically
download the EPID with correct data for that patient and
field. ~3! Image the patient and take action as the protocol
directs. The action may include doing nothing, performing
on-line or off-line setup correction. If the EPID is part of the
information system, recording, storing, and retrieving the im-
age may be simplified.
2. On-line EPID use
An early group of on-line EPID studies involved taking
prospective action based on a pretreatment port. This type of
protocol has been implemented in a number of centers and
allows the reduction of both random and systematic errors
for each individual patient, but does not differentiate be-
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studies indicate that up to 50% of initial fields are judged in
error and corrected. The error correction rate is anatomical
site dependent and due to the visual analysis, observer de-
pendent as well. While improvement in setup accuracy was
noted in these studies, final off-line analysis shows that some
residual setup error remained. An example of on-line setup
correction and final error is shown in Fig. 13.17 Visual analy-
sis is not quantitative and as shown in Fig. 13, even after
correction, quantitative off-line analysis found that 15% of
setups were still in error by more than 5 mm. In addition,
these studies depend primarily on two-dimensional analysis
and manual patient setup correction can increase treatment
time. For these reasons, daily on-line EPID imaging is not
practiced in many centers. There are, however, examples of
on-line correction strategies in use today, where the clini-
cians feel that the additional time to make a correction is
warranted.91
More quantitative daily correction approaches have been
developed, which utilize automated image analysis tools, de-
veloped commercially or in-house, to substantially increase
accuracy, with modest increase in effort. A computer-aided
on-line analysis and correction system has been implemented
to correct pelvic and thoracic treatment setup errors
daily.21,24 While these studies showed a significant improve-
ment in setup accuracy, additional treatment time was re-
quired, due to the need to adjust patient setup. The comput-
erized nature of the EPID allows it to be integrated into a
larger scale decision-making system. Such an integrated sys-
tem can help the users decide when it is appropriate to make
a correction and when not to, based on the established phy-
sician and treatment planning guidelines.92 The quest for im-
proved efficiency and automation in the use of EPIDs is
ongoing and pursued both by research groups and vendors.
3. Off-line EPID use
Off-line EPID models can be separated into three groups,
simple off-line correction ~film model!, monitoring, and sta-
tistical decision models.
a. Simple off-line. The simplest use of the EPID is to
replace weekly portal filming, where the EPID is used to
FIG. 13. Results of intrafractional corrections and final errors for various
sites. The bar graph indicates how often corrections were made and what
percentage of final errors were in each of three ranges. Modified from Ref.
17 with permission from Elsevier Science.Medical Physics, Vol. 28, No. 5, May 2001generate hard copy as with film @Fig. 12~b!#. The EPID also
provides additional benefits compared to film; faster imaging
time and image enhancement ~e.g., contrast enhancement,
edge enhancement! algorithms can be applied immediately.
Error detection can be accomplished manually, with com-
puter assistance in an interactive mode, or automatically.
b. Monitoring. The earliest clinical EPID studies were of
the monitoring type, where images are acquired, but no ac-
tion is taken. Lam described the frequency and magnitude of
field placement errors ~FPEs! in thoracic and abdominal ra-
diotherapy, suggesting that errors exceeding conventional
planning margins may not be uncommon.93 Others have cre-
ated summary data showing the cumulative effect of daily
FPEs on the course of radiotherapy for individual patients94
and then extended the methodology to indicate the effects of
FPEs on treated doses.95 This strategy has also been utilized
to determine time trends in patient setup accuracy, showing
that patient setup error can increase during the course of
therapy and that routine imaging is essential to maintain ac-
curate treatment.96
Movie loops have been used to monitor target and normal
tissue motion between and during treatment fractions during
tangential breast field treatment.7,16,97 The comprehensive
analysis enabled by EPID use shows the magnitude and fre-
quency of setup and motion errors for a group of patients and
more importantly for individual patients. An example of mo-
tion of the lung–chest wall interface seen through six to
seven images during each treatment fraction is shown in Fig.
14, indicating the wide range of motion that occurs due to
respiration during treatment.98 Daily and weekly imaging
samples are also indicated in the figure. It is clear that
weekly portal imaging cannot be used to quantify tissue mo-
tion due to respiration, which can exceed 2 cm during tan-
gential breast treatments.22
Prostate motion studies using radio-opaque markers show
that while the prostatic tissue relative to bony pelvis does not
move appreciably during treatment, it can move over 1.5 cm
relative to the bones between fractions.99 Other pelvic setup
studies show that setup errors exceeding 1 cm were not un-
common, and that these intertreatment values exceed any
intrafractional motion errors for the pelvis.100
c. Statistical models/decision rules. Statistical models
FIG. 14. Displacement results ~in mm! of the lung–chest wall interface
measured during movie-loop imaging over multiple fractions. Daily imaging
points are shown as arrows and weekly imaging as ~W! ~Ref. 98!.
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treatments without a large increase in time or cost for the
information. Two examples are presented.
Decision rule example 1 ~analysis based on a global stan-
dard!: A systematic error correction protocol based on estab-
lishing error thresholds derived from a patient population for
a specific treatment site has been discussed.20,23,29 The need
to correct systematic error for any patient is evaluated with
respect to this institutional or global threshold. These studies
have demonstrated that reduction of systematic error of ap-
proximately a factor of 2 ~compared to uncorrected! is
achievable, with an average of less than 10 images and ap-
proximately 0.5 corrections per patient treatment course ~Fig.
15!. In other words, with about the same imaging effort as
film, and the tools of the EPID, significant error reduction
can be achieved.
Decision rule example 2 ~analysis based on an individual
standard!: The ability to gather enough data to make system-
atic and random error assessment on individual patients with
EPID has also been introduced. In the population-based cor-
rection models, the setup errors are assessed for all patients
@plotted in Fig. 16~a!#. If an EPID is used to acquire daily
portal images for individual patients, then the data in Fig.
16~a! can be replotted in Fig. 16~b! as the average setup
variation for each of 25 pelvic patients. Clearly, the margin
of 11 mm ~arrow! is unnecessarily large for an appreciable
number of the patients, and yet inadequate for 2 patients. The
FIG. 15. Three-dimensional setup variation in Dutch prostate study ~Ref.
29!.Medical Physics, Vol. 28, No. 5, May 2001data also suggest that some patients are highly reproducible
in their daily setup. Individual treatment margins can be re-
optimized for a specific margin reduction so that a higher
dose might be delivered.
The concept of adaptive radiation therapy has been intro-
duced by Yan et al. as a closed-loop feedback process for
correction of the individual patient setup error.101,102 Extend-
ing the idea by Denham103 on the optimal frequency to take
daily portal images, the nature of treatment variations are
characterized for a few fractions early in the course of treat-
ment such that they can be confidently estimated for the
remaining course of treatment. This allows for the applica-
tion of patient specific treatment corrections. Similar work in
the use of EPID for early error detection and correction for
dose escalation protocols is also underway.104
D. Advanced applications
1. Treatment QA
The EPID has also been put to use for quality assurance
of treatment machines64,105 and of treatment techniques, such
as radiosurgery106 and dynamic treatment delivery.107–109 In-
vestigators have used the EPID for the design110,111 and
verification112 of compensating filters In each case, the EPID
has allowed more precise, quantitative results to be obtained
with much less effort than would have been achievable using
conventional QA tools.
2. Exit dosimetry
More recently, there has been much interest in determin-
ing in vivo dose distributions during treatment with an EPID.
While setup error and patient motion are quantified with
EPID imaging, the ultimate value of concern is dose to target
and normal tissue. Efforts to determine and quantify dose in
two and three dimensions are under way. The earliest works
investigated the characteristics of the various EPIDs for
transmission dose measurement.65,113–116 These studies indi-
cate that with the proper calibration and care, the EPID can
be used to generate an exit dose image and values that are
within 2%–5% of expected values. Additional work hasFIG. 16. ~a! Margin ~arrow! based on population statistics ~b! replotted for individual patients, showing that the margin would not be optimum for all patients.
733 Herman et al.: TG58 733gone into the interpretation of the EPID image in terms of a
quantitative exit dose and implications for dose at the
target.117,118 It should be noted that there may be significant
differences related to quality control and calibration prob-
lems in determining dose with an EPID and extreme caution
should be used.
VI. COST AND FUTURE
A. Cost
The major expense for an EPID is the initial cost ranging
from $80,000 to $250,000 ~in 1999!. The comparable initial
expense for film portal imaging is about $20,000. However,
the ongoing costs for film portal imaging are substantial,
where the EPID ongoing equipment and per image costs are
almost negligible. The extra amount of time and labor
needed to process film and display it for review is expensive,
but varies depending on location and who performs the
FIG. 17. Annual cost of portal imaging EPID and film vs imaging frequency.Medical Physics, Vol. 28, No. 5, May 2001work. It has been shown that for large centers, or even
smaller centers that image frequently, EPIDs can be more
cost effective than film.119 It is therefore expected that with
more frequent use, an EPID should be more economical than
film. Figure 17 shows changes in total annual cost of imag-
ing with film and EPID as a function of increasing use of
portal imaging based on the usage model of a TG 58 mem-
ber. The absolute numbers on each axis need to be adjusted
for individual situations. The graph shows clearly that if por-
tal imaging is performed frequently, then EPID is less expen-
sive to use than film. Analyses such as these must consider
capital costs, annual maintenance, and personnel time. It is
important to note that this cost analysis treats EPID and film
as identical in clinical value, ignoring the fact that the EPID
is far more powerful than film for error analysis and in some
cases can do things that cannot be done with film. Quantify-
ing personnel costs specific to expected utilization of an
EPID will help assess the economic impact of EPID use. The
choice of correction strategy of any EPID protocol has the
most direct impact on the allocation of personnel and com-
puter resources. Table VII lists estimates of the necessary
resources to implement various correction strategies. These
estimates are based on imaging all patients at 2.5 fields per
patient. Four strategies are distinguished. The first column
pertains to the simplest strategy where images are inspected
visually on-line to prevent gross error. The tolerance for cor-
rection should be set large so as not to impede treatment
throughput but also to avoid erroneous correction. Images
are not archived for analysis and the strategy incurs minimal
cost. The second column presents perhaps the most complex
and sophisticated use of the EPID where setup error is as-
sessed and corrected on a daily basis. This strategy corrects
for both systematic and random error, and in theory, shouldTABLE VII. Estimates of personnel ~FTF! and computer resources necessary for four correction strategies that
can be used with an EPID, based on 2.5 treatment ports per patient.
On-line
visual
On-line
quantitative
Off-line a
~weekly film model!
Off-line b
~statistical
model!
Tolerance ~mm! 7.0 2.0 3.0–5.0 2.0
Physics/computer
~FTE!
0.1 ~QA! 0.2 ~QA! 0.3
~0.2 QA, 0.1support!
0.3
Operatora ~FTF! 0.05
~deploy!
0.10, pre-Tx
localization
0.05 0.05
Evaluator ~FTE! 0.02 0.05 ~much
increased if
performed daily!
0.05 0.3b
Software utility
beyond standard
image acquisition
software
0 Quantitative
measurement tools
Quantitative
measurement tools,
annotation
Quantitative
measurement
tools,
annotation,
statistical
model
Hardware 0 Reference image
import,
record of event
Review station,
Reference image
import, ~hardcopy?!
Analysis
station,
reference
image import
aOperator indicates treatment machine time.
bIncludes error analysis and statistical model/decision rule analysis for all patients.
734 Herman et al.: TG58 734achieve the highest accuracy. However, this strategy can also
be most costly in terms of time and effort. The third column
is for an off-line correction strategy that is similar to the
weekly port film practice. Additional software and hardware
options can be very helpful. The final column represents the
off-line strategy that is based on statistical decision models.
The approach requires the commitment of personnel and
computer resources to archive and analyze the data, but also
provides the potential for reduction of effort at the treatment
unit. For example, field placement error can be corrected by
moving a multileaf collimator via network. Note that the
associated resource costs stated for the four strategies are
estimates of total cost. This should be compared to film im-
aging @similar to column off-line ~a!#. For larger depart-
ments, some economy of scale should be expected.
B. Future
Modern technology is yielding new flat panel AMFPI ra-
diographic detectors. These devices take two forms: photo-
diode arrays ~e.g., amorphous silicon arrays!52–54,120–122 and
photoconductor arrays ~e.g., amorphous selenium
arrays!.55–61,123 These devices show promise to yield image
quality superior to film, with all the power of an EPID. The
amorphous silicon arrays have excellent imaging character-
istics. Measurements have shown that these devices are x-ray
quantum limited,124 while other reports suggest that, apart
from the finite pixel size, the amorphous silicon array light
sensor has a negligible effect on spatial resolution of the
EPID.125–127 These detectors are capable of providing verifi-
cation for advanced treatment delivery systems such as those
used in IMRT.
New technology applied to setup and portal verification is
also being developed. The approaches include the use of ki-
lovoltage x-ray beams,128–131 the use of video camera posi-
tioning systems,132,133 and ultrasound.134–138
It is very important to note that the data infrastructure and
the clinical utilization process must be understood to fully
take advantage of any new or advanced technology.
VII. SUMMARY AND RECOMMENDATIONS
The TG 58 report was written to enhance the knowledge
of the medical physicist in implementing EPID technology in
the clinic. From reading this report, the reader should under-
stand the following.
~1! The basic physical principles of image formation and
megavoltage imaging. This provides the reader with the es-
sential background necessary to understand the function,
limitations, and quality assurance of EPID systems.
~2! The technical and practical manifestations of the
megavoltage imagers. This gives the reader an understanding
of the hardware, software, and production characteristics of
commercially available systems. Critical components related
to image quality, EPID operation, performance, and safety
are indicated and must be understood for optimal clinical
use.
~3! Details of installation, commissioning, and developing
and performing continuing quality assurance. Essential char-Medical Physics, Vol. 28, No. 5, May 2001acteristics to consider and steps to be taken to bring EPID
technology into the clinic, verify proper operation, and es-
tablish a viable quality assurance program are provided.
~4! Critical questions that should be discussed to help the
reader prepare for the purchase, installation, and continuing
effective use of an EPID. This includes understanding the
clinical situation and potential resource commitments.
~5! Availability and operation of various image acquisi-
tion, enhancement, and analysis software to make appropri-
ate equipment selection and specifications.
~6! The models of successful clinical EPID use, which
demonstrate a wide variety of application from simple to
sophisticated. Reading these references provides detailed in-
formation on the cost, benefit, and implementation of each
EPID protocol.
~7! How to establish costs for EPID implementation, from
capital equipment to human resources. Choice of clinical ap-
plication has a strong influence on total costs.
~8! That the technology for EPID is changing and improv-
ing. Any purchase should consider upgrades in both software
and hardware.
This task group recommends that:
~i! The medical physicist become familiar with the phys-
ics of megavoltage portal imaging ~Sec. II! and its
commercial manifestations ~Sec. III!. This informa-
tion allows the reader to establish clear specifications
and to maintain an effective EPID.
~ii! The medical physicist understand the details of the
installation, commissioning, and the QA process of an
EPID ~Sec. IV!. Only if these issues are understood
can the physicist be prepared to bring the EPID sys-
tem into the clinic and maintain the system at opti-
mum performance.
~iii! The treatment team evaluate the tables in Sec. V re-
garding clinical use, resource commitment, and edu-
cation. Since each clinical use of EPID may be differ-
ent, evaluating these issues before selecting and
implementing an EPID is paramount.
~iv! The medical physicist evaluate ongoing education,
upgrades, and clinical uses of EPID to remain knowl-
edgeable in maintaining and improving the quality of
EPID application.
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